ADVERTISEMENT
Advertise

Content

List volumes - List articles in this issue

Clinical Report

In vitro Cytokine Expression by Peripheral Mononuclear Cells in Herbal Drug-induced Skin Eruption

doi: 10.2340/00015555-1631

Abstract:

Herbal medicine is widely used worldwide and is associated with side-effects such as skin eruptions. Herbal drugs are often produced by combining multiple crude drugs, mostly of plant origin. Determining which medi-cinal plants are associated with the herbal drugs that induce skin eruptions can therefore be difficult. This study investigated mRNA expression of several cytokines in peripheral mononuclear cells (PBMCs) from two patients with herbal drug-induced skin eruptions; one reacted to keishi-bukuryo-gan (KBG), composed of 5 medicinal plants, and the other patient reacted to senna. PBMCs (1×106) from the 2 patients were cultured for 24 h with the supernatant from the medicinal plants from KBG or senna in various concentrations, and a reverse transcription-polymerase chain reaction (RT-PCR) analysis was performed. A high mRNA level of interleukin (IL)-4 and IL-5 was detected in PBMCs stimulated by KBG and two of its components. Senna stimulated a high level of IL-4 and IL-5 mRNA levels in PBMCs from patient with senna-induced drug reaction.

Authors:

Osamu Norisugi, Yoko Yoshihisa, Kyoko Shimizu, Tadamichi Shimizu
Department of Dermatology, Graduate School of Medicine, University of Toyama, Sugitani, Toyama, Japan.

References

1. Kawasaki A, Mizushima Y, Kunitani H, Kitagawa M, Kobayashi M. A useful diagnostic method for drug-induced pneumonitis: a case report. Am J Chin Med 1994; 22: 329–336.

2. Vanherweg
hem JL, Depierreux M, Tielemans C, Abramowicz D, Dratwa M, Jadoul M, et al. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet 1993; 341: 387–391.

3. Kane JA,
Kane SP, Jain S. Hepatitis induced by traditional Chinese herbs; possible toxic components. Gut 1995; 36: 146–147.

4. Furuichi M, Hara H, Asano Y, Makino T, Shimizu T. Fixed drug eruption caused by the Japanese herbal drug kakkonto. Dermatol Online J 2010; 15: 13.

5. Tan WP, Goh BK, Tan SH. Extensive erythema multiforme-like eruption due to traditional Chinese herbal drug ‘Dong Ling Hou Tong Pian’. Clin Exp Dermatol 2006; 31: 291–293.

6. Ikegami F, Fujii Y, Satoh T. Toxicological considerations of Kampo medicines in clinical use. Toxicology 2004; 198: 221–228.

7. Yoshihisa
Y, Furuichi M, Rehman MU, Ueda C, Makino T, Shimizu T, The traditional Japanese formula keishibukuryogan inhibits the production of inflammatory cytokines by dermal endothelial cells. Mediators Inflamm 2010; Epub 2010 Dec 28.

8. van Gorkom BAP, Karrenbeld A, van der Sluis T, Koudstaal J, de Vries EG, Kleibeuker JH. Influence of a highly purified senna extract on colonic epithelium. Digestion 2000; 61: 113–120.

9. Gessner A, Mohrs K, Mohrs M. Mast cells, basophils, and eosinophils acquire constitutive IL-4 and IL-13 transcripts during lineage differentiation that are sufficient for rapid cytokine production. J Immunol 2005; 174: 1063–1072.

10. Lampinen M, Carlson M, Hakansson LD, Venge P. Cytokine-regulated accumulation of eosinophils in inflammatory disease. Allergy 2004; 59: 793–805.

11. Shimizu T, Abe R, Ohkawara A, Nishihira J. Increased production of macrophage migration inhibitory factor (MIF) by PBMCs of atopic dermatitis. J Allergy Clin Immunol 1999; 104: 659–664.

12. Mikami C, Ochiai K, Kagami M, Tomioka H, Tanabe E. In vitro interleukin-5 (IL-5) production by peripheral blood mononuclear cells from patients with drug hypersensitivity. J Dermatol 1996; 23: 379–381.

13. Mizawa M, Makino T, Hikiami T, Shimada Y, Shimizu T. Effectiveness of keishibukuryogan on chronic-stage lichenification associated with atopic dermatitis. ISRN Dermatol 2012: Epub 2012 Nov 14.

14. Itoh T, Terasawa K, Kohta K, Shibahara N, Tosa H, Hiyama Y. Effects of Keishi-bukuryo-gan and Trapidil on the microcirculation in patients with cerebro-spinal vascular disease. J Med Pharmaceut Soc for WAKAN-YAKU 1992; 9: 40–46.

15. Hikiami H, Goto H, Sekiya N, Hattori N, Sakakibara I, Shimada Y, et al. Comparative efficacy of Keishi-bukuryo-gan and pentoxifylline on RBC deformability in patients with “oketsu” syndrome. Phytomedicine 2003; 10: 459–466.

16. Kohta K, Hikiami H, Shimada Y, Matsuda H, Hamazaki T, Terasawa K. Effects of Keishi-bukuryo-gan on erythrocyte aggregability in patients with multiple old lacunar infarction. J Med Pharmaceut Soc for WAKAN-YAKU 1993; 10: 251–259.

17. Tosa H, Toriizuka K, Terasawa K. The effect of Keishi-bukuryogan on blood viscosity and blood coagulation in normal subjects,” J Med Pharmaceut Soc for WAKAN-YAKU 1987; 4: 172–179.

18. Steer HW, Colin-Jones DG. Melanosis coli: studies of the toxic effects of irritant purgatives. J Pathol 1975; 115: 199–205.

19. Toshitani S, Koga T, Nonaka Y. [A case of urticaria-like drug eruption induced by sennoside (laxativee).] Allergol Immunol 1998; 5: 206–209 (in Japanese).

20. Sugita K, Izu K, Tokura Y. Erythema multiforme-like drug eruption caused by sennoside. Int J Dermatol 2006; 45: 1123.

21. Mochitomi Y, Inoue A, Kawabata H, Ishida S, Kanzaki T. Stevens-Johnson syndrome caused by a health drink (Eberu) containing ophiopogonis tuber. J Dermatol 1998; 25: 662–665.

22. Okuda T, Umezawa Y, Ichikawa M, Hirata M, Oh-i T, Koga M.A case of drug eruption caused by the crude drug Boi (Sinomenium stem/Sinomeni caulis et Rhizoma). J Dermatol 1995; 22: 795–800.

23. Fujita Y, Shimizu T, Shimizu H. A case of interstitial granulomatous drug reaction due to sennoside. Br J Dermatol 2004; 150: 1035–1037.

24. Nishimura A, Natsuaki M, Yamanishi K. Study on the drug-induced lymphocyte stimulatin test for kampo medicine in healthy volunteers (in Japanese). Skin Res 2010; 9: 452–457.

25. Tan C, Zhu WY. Chinese herbal medicine: a neglected offender for fixed drug eruptions. Eur J Dermatol 2010; 20: 1–2.

Related articles

There are no related articles.


Share with your friends





Actions


Abstract

Full text

PDF

Supplementary


Figure S1
Figure S2

Print information


Volume 94, Issue 1

DOI: 10.2340/00015555-1631

Pages: 58-62

View at PubMed